Table 1.
Standard-dose Chemotherapy |
Myeloablative Chemotherapy |
P-value | |
---|---|---|---|
Numbers of patients | 56 | 27 | |
Characteristics | |||
Median age in years (range) | 11.1 (0.1–19.3) | 8.5 (0.2–20.9) | .25 |
Age ≤ 3 years | 7 (12%) | 6 (22%) | .33 |
Females | 27 (48%) | 12 (44%) | .82 |
Spinal Cord Primaries | 2 (4%) | 3 (8%) | >0.3 |
Neuropathology | 0.25 | ||
Glioblastoma Multiforme | 27 (48%) | 17 (63%) | |
Anaplastic Astrocytoma | 29 (52%) | 10 (37%) |